Showing results (641-650 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|May 7, 2005
Changing health environment: the challenge to demonstrate cost-effectiveness of new compoundsBengt Jönsson
Pharmacoeconomics|September 1, 2006
Using discrete choice experiments within a cost-benefit analysis framework: some considerationsEmma McIntosh
Pharmacoeconomics|October 27, 2007
Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis BDavid L Veenstra, Sean D Sullivan, Lauren Clarke, et al.
Pharmacoeconomics|April 24, 2008
Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health StatesNick Bansback, Roberta Ara, Jonathan Karnon, et al.
Pharmacoeconomics|March 13, 2010
Pharmacoeconomic evaluation in Ireland: a review of the processLesley Tilson, Aisling O'Leary, Cara Usher, et al.
Pharmacoeconomics|November 14, 2009
Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expectedAllan Wailoo, Aki Tsuchiya, Christopher McCabe
Pharmacoeconomics|August 29, 2009
A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processesGianluca Baio, Pierluigi Russo
Pharmacoeconomics|September 14, 2010
Comparative effectiveness regulations and pharmaceutical innovationJohn A Vernon, Joseph H Golec, J Stedman Stevens
Pharmacoeconomics|November 9, 2023
A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover EffectsRamesh Lamsal, E Ann Yeh, Eleanor Pullenayegum, et al.
Pharmacoeconomics|March 11, 2026
Evaluating the Cost Effectiveness of Rapid Diagnostic Testing for the Identification of Pathogens and Resistance Genes in Bloodstream InfectionsJames K Karichu, Mark Pennington, Xiyu Bao, et al.
Pageof 335